Comera Life Sciences Holdings, Inc. Stock
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0278 USD | +22.25% | +21.40% | -49.45% |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Financials (USD)
Sales 2021 | 320K | Sales 2022 | 633K | Capitalization | 24.41M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -18M | EV / Sales 2021 | 400 x |
Net cash position 2021 | 6.19M | Net Debt 2022 | 328K | EV / Sales 2022 | 39.1 x |
P/E ratio 2021 |
-7.26
x | P/E ratio 2022 |
-0.7
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.53% |
1 day | +22.25% | ||
1 week | -5.12% | ||
Current month | +22.47% | ||
1 month | -7.33% | ||
3 months | -33.81% | ||
6 months | -66.10% | ||
Current year | -49.45% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 22-04-12 |
Corporate Officer/Principal | - | 22-11-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 22-05-18 |
James Sherblom
BRD | Director/Board Member | 68 | 20-12-31 |
Director/Board Member | 48 | 22-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.0278 | +22.25% | 2,183 |
24-06-03 | 0.0227 | 0.00% | 11,529 |
24-05-31 | 0.0227 | 0.00% | 1,104 |
24-05-30 | 0.0227 | -0.87% | 3,685 |
Delayed Quote OTC Markets, June 04, 2024 at 12:29 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-49.45% | 698K | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- CMRA Stock